Literature DB >> 30497961

53BP1: A key player of DNA damage response with critical functions in cancer.

Mohammad Mirza-Aghazadeh-Attari1, Amir Mohammadzadeh1, Bahman Yousefi2, Ainaz Mihanfar3, Ansar Karimian4, Maryam Majidinia5.   

Abstract

Maintenance of genome integrity and stability is a critical responsibility of the DNA damage response (DDR) within cells, such that any disruption in this kinase-based signaling pathway leads to development of various disorders, particularly cancer. The tumor suppressor P53-binding protein 1 (53BP1), as one of the main mediators of DDR, plays a pivotal role in orchestrating the choice of double-strand break (DSB) repair pathway and contains interaction surfaces for numerous DSB-responsive proteins. It has been extensively demonstrated that aberrant expression of 53BP1 contributes to tumor occurrence and development. 53BP1 loss of function in tumor tissues is also related to tumor progression and poor prognosis in human malignancies. Due to undeniable importance of this protein in various aspects of cancer initiation/progression, angiogenesis, metastasis and development of drug resistance, as well as its targeting in the treatment of cancer, this review focused on explaining the structure and function of 53BP1 and its contribution to cancer.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  53BP1; Cancer; DNA damage response; DNA repair; Double strand breaks

Mesh:

Substances:

Year:  2018        PMID: 30497961     DOI: 10.1016/j.dnarep.2018.11.008

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  28 in total

Review 1.  Role of deubiquitinases in DNA damage response.

Authors:  John Le; Eric Perez; Leah Nemzow; Feng Gong
Journal:  DNA Repair (Amst)       Date:  2019-02-21

Review 2.  Human polyomavirus modulation of the host DNA damage response.

Authors:  Danyal Tahseen; Peter L Rady; Stephen K Tyring
Journal:  Virus Genes       Date:  2020-01-29       Impact factor: 2.332

Review 3.  Phase separation drives tumor pathogenesis and evolution: all roads lead to Rome.

Authors:  Xiang Gu; Ai Zhuang; Jie Yu; Peiwei Chai; Renbing Jia; Jing Ruan
Journal:  Oncogene       Date:  2022-02-08       Impact factor: 9.867

4.  Quantification of radiation-induced DNA double strand break repair foci to evaluate and predict biological responses to ionizing radiation.

Authors:  Sébastien Penninckx; Eloise Pariset; Egle Cekanaviciute; Sylvain V Costes
Journal:  NAR Cancer       Date:  2021-12-22

5.  53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  Ai Huang; Yong Xiao; Chunfen Peng; Tao Liu; Zhenyu Lin; Qin Yang; Tao Zhang; Jun Liu; Hong Ma
Journal:  Strahlenther Onkol       Date:  2019-12-11       Impact factor: 3.621

Review 6.  Biomolecular Condensates and Cancer.

Authors:  Ann Boija; Isaac A Klein; Richard A Young
Journal:  Cancer Cell       Date:  2021-01-07       Impact factor: 31.743

7.  Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours.

Authors:  Madushan Fernando; Pascal H G Duijf; Martina Proctor; Alexander J Stevenson; Anna Ehmann; Shivam Vora; Dubravka Skalamera; Mark Adams; Brian Gabrielli
Journal:  Oncogenesis       Date:  2021-05-15       Impact factor: 7.485

8.  APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites.

Authors:  Daniel Constantin; Gilles Dubuis; María Del Carmen Conde-Rubio; Christian Widmann
Journal:  FEBS J       Date:  2021-10-04       Impact factor: 5.622

9.  SMC5/6 is required for replication fork stability and faithful chromosome segregation during neurogenesis.

Authors:  Alisa Atkins; Michelle J Xu; Maggie Li; Nathaniel P Rogers; Marina V Pryzhkova; Philip W Jordan
Journal:  Elife       Date:  2020-11-17       Impact factor: 8.140

Review 10.  Role of Dietary Antioxidants in p53-Mediated Cancer Chemoprevention and Tumor Suppression.

Authors:  J P Jose Merlin; H P Vasantha Rupasinghe; Graham Dellaire; Kieran Murphy
Journal:  Oxid Med Cell Longev       Date:  2021-06-26       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.